Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine Wesseling-Perry

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|July 17, 2010
Value of the new bone classification system in pediatric renal osteodystrophySevcan A Bakkaloglu, Katherine Wesseling-Perry, Renata C Pereira, et al.
Kidney International|September 24, 2010
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidismKatherine Wesseling-Perry, Renata C Pereira, Shobha Sahney, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 6, 2013
The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trialJustine Bacchetta, Katherine Wesseling-Perry, Beatriz Kuizon, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysisKatherine Wesseling-Perry, Renata C Pereira, Hejing Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2016
Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot StudyVille-Valtteri Välimäki, Outi Mäkitie, Renata Pereira, et al.
Pediatric Nephrology (Berlin, Germany)|March 21, 2009
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterolsKatherine Wesseling-Perry, G Chris Harkins, He-Jing Wang, et al.
Kidney International|October 30, 2014
Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivoRenata C Pereira, Anne M Delany, Nadine M Khouzam, et al.
The Journal of Nutrition|February 14, 2014
Short sleep duration is associated with higher energy intake and expenditure among African-American and non-Hispanic white adultsRuth E Patterson, Jennifer A Emond, Loki Natarajan, et al.
JBMR Plus|April 18, 2022
Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis PatientsOrnatcha Sirimongkolchaiyakul, Katherine Wesseling-Perry, Barbara Gales, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2017
Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3Katherine Wesseling-Perry, Riikka E Mäkitie, Ville-Valtteri Välimäki, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Clinical Journal of the American Society of Nephrology : CJASN|July 17, 2010
Value of the new bone classification system in pediatric renal osteodystrophySevcan A Bakkaloglu, Katherine Wesseling-Perry, Renata C Pereira, et al.
Kidney International|September 24, 2010
Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidismKatherine Wesseling-Perry, Renata C Pereira, Shobha Sahney, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 6, 2013
The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trialJustine Bacchetta, Katherine Wesseling-Perry, Beatriz Kuizon, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysisKatherine Wesseling-Perry, Renata C Pereira, Hejing Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2016
Teriparatide Treatment in Patients With WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis: A Pilot StudyVille-Valtteri Välimäki, Outi Mäkitie, Renata Pereira, et al.
Pediatric Nephrology (Berlin, Germany)|March 21, 2009
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterolsKatherine Wesseling-Perry, G Chris Harkins, He-Jing Wang, et al.
Kidney International|October 30, 2014
Primary osteoblast-like cells from patients with end-stage kidney disease reflect gene expression, proliferation, and mineralization characteristics ex vivoRenata C Pereira, Anne M Delany, Nadine M Khouzam, et al.
The Journal of Nutrition|February 14, 2014
Short sleep duration is associated with higher energy intake and expenditure among African-American and non-Hispanic white adultsRuth E Patterson, Jennifer A Emond, Loki Natarajan, et al.
JBMR Plus|April 18, 2022
Effects of Primary Kidney Disease Etiology on Renal Osteodystrophy in Pediatric Dialysis PatientsOrnatcha Sirimongkolchaiyakul, Katherine Wesseling-Perry, Barbara Gales, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2017
Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3Katherine Wesseling-Perry, Riikka E Mäkitie, Ville-Valtteri Välimäki, et al.
Pageof 7